clenbuterol has been researched along with Fatty Liver in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "C57Bl/6N mice with diet-induced obesity were treated both acutely and for up to 42 days with a wide range of clenbuterol dosages and treatment durations." | 3.96 | Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity. ( Åslund, A; Bengtsson, T; Berlin, R; Dehvari, N; Forsberg, E; Halleskog, C; Hoeks, J; Kalinovich, A; Olsen, J; Östenson, CG; Rinde, M; Sandström, A; Schaart, G; van Beek, S; Zacharewicz, E, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalinovich, A | 1 |
| Dehvari, N | 1 |
| Åslund, A | 1 |
| van Beek, S | 1 |
| Halleskog, C | 1 |
| Olsen, J | 1 |
| Forsberg, E | 1 |
| Zacharewicz, E | 1 |
| Schaart, G | 1 |
| Rinde, M | 1 |
| Sandström, A | 1 |
| Berlin, R | 1 |
| Östenson, CG | 1 |
| Hoeks, J | 1 |
| Bengtsson, T | 1 |
1 other study available for clenbuterol and Fatty Liver
| Article | Year |
|---|---|
Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Clenbuterol; Fatty Liver; Glucose; Homeostasis; Insuli | 2020 |